Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2025-12-01 00:00:00 ET · period of report 2025-12-01 · accession 0001193125-25-303941 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-01 | 2025-12-01 | SNDX | Goldan Keith A. | CFO | G - Gift | $0.00 | -1,224 | 92.5K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | G | D | 1,224 | $0.00 | 92,452 | D | — | — |